Original Research

Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis

Dranitsaris G, Shane LG, Crowther M, Feugere G, Woodruff S

ClinicoEconomics and Outcomes Research 2017, 9:65-73

Published Date: 10 January 2017